Triple Flag Precious Metals Corp (TFPM)vsVersamet Royalties Corporation Common Stock (VMET)
TFPM
Triple Flag Precious Metals Corp
$31.98
-6.52%
BASIC MATERIALS · Cap: $7.34B
VMET
Versamet Royalties Corporation Common Stock
$10.83
-4.41%
BASIC MATERIALS · Cap: $1.32B
Smart Verdict
WallStSmart Research — data-driven comparison
Triple Flag Precious Metals Corp generates 1204% more annual revenue ($453.45M vs $34.76M). TFPM leads profitability with a 68.7% profit margin vs 58.5%. TFPM trades at a lower P/E of 23.5x. TFPM earns a higher WallStSmart Score of 67/100 (B-).
TFPM
Strong Buy67
out of 100
Grade: B-
VMET
Hold45
out of 100
Grade: D+
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Keeps 69 of every $100 in revenue as profit
Strong operational efficiency at 66.9%
Revenue surging 78.7% year-over-year
Earnings expanding 147.2% YoY
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Keeps 59 of every $100 in revenue as profit
Strong operational efficiency at 135.6%
Revenue surging 465.2% year-over-year
Areas to Watch
No major concerns identified
0.0% earnings growth
Smaller company, higher risk/reward
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : TFPM
The strongest argument for TFPM centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 68.7% and operating margin at 66.9%. Revenue growth of 78.7% demonstrates continued momentum.
Bull Case : VMET
The strongest argument for VMET centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 58.5% and operating margin at 135.6%. Revenue growth of 465.2% demonstrates continued momentum.
Bear Case : TFPM
No major red flags identified for TFPM, but monitor valuation.
Bear Case : VMET
The primary concerns for VMET are EPS Growth, Market Cap, P/E Ratio. A P/E of 58.0x leaves little room for execution misses.
Key Dynamics to Monitor
VMET is growing revenue faster at 465.2% — sustainability is the question.
TFPM generates stronger free cash flow (82M), providing more financial flexibility.
Monitor OTHER PRECIOUS METALS & MINING industry trends, competitive dynamics, and regulatory changes.
Bottom Line
TFPM scores higher overall (67/100 vs 45/100), backed by strong 68.7% margins and 78.7% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Triple Flag Precious Metals Corp
BASIC MATERIALS · OTHER PRECIOUS METALS & MINING · USA
Triple Flag Precious Metals Corp (TFPM) is a premier precious metals streaming and royalty company, focused on delivering innovative capital solutions to the mining sector by securing a portion of future production. The company boasts a highly diversified portfolio across established mining jurisdictions, enabling it to effectively mitigate operational risks while leveraging the growing global demand for gold and silver. Through its distinctive financial model, TFPM not only underpins mining operations but also aligns itself with favorable price movements in the precious metals market. With a strong management team and robust balance sheet, Triple Flag is strategically positioned to seize sustainable mining opportunities, appealing to institutional investors seeking resilience and growth within their commodity portfolios.
Visit Website →Versamet Royalties Corporation Common Stock
BASIC MATERIALS · OTHER PRECIOUS METALS & MINING · USA
Viamet Pharmaceuticals Corp (VMET) is a biopharmaceutical company focused on developing novel therapeutics for serious and life-threatening diseases, particularly through its innovative drug development platform that leverages its proprietary metalloenzyme-based technology. The company aims to address unmet medical needs in areas such as fungal infections and oncology, positioning itself at the forefront of therapeutic innovation. Viamet's strategic partnerships and strong intellectual property portfolio underscore its commitment to advancing its pipeline while maximizing shareholder value. As it progresses through clinical development phases, VMET stands to play a significant role in transforming treatment paradigms within its targeted therapeutic areas.
Compare with Other OTHER PRECIOUS METALS & MINING Stocks
Want to dig deeper into these stocks?